In the context of PDAC, our group has demonstrated that low-dose PDT followed by chemotherapy significantly reduces stem-like tumor cell populations that are known to contribute to treatment resistance and metastatic potential, in part through the downregulation of CD44 and CXCR4. The gene discussed is CD44; the disease is neoplasm.